EL7.AI
Stocks•16 November 2026•
1 min read

Apnimed and EGH Acquisition Report Third Quarter 2026 Financial Results

Key Facts

1Apnimed reported a net loss of $29.5 million for the third quarter of 2026.
2Apnimed maintains a strong cash position of $351.8 million following its August 2026 IPO.
3EGH Acquisition Corp. reported earnings per share of $0.05 for the quarter ending September 30, 2026.

Apnimed reported a net loss of $29.5 million for the third quarter of 2026, according to Benzinga. Meanwhile, EGH Acquisition Corp. reported earnings per share of $0.05 for the quarter ending September 30, 2026, highlighting the distinct financial outcomes for both entities during the period.

Apnimed maintains a strong cash position of $351.8 million as of September 30, 2026, following its initial public offering in August 2026. Regarding equity performance, EGHA closed at $10.47 on November 13, 2026.

Open on chart